riluzole has been researched along with Insulin Resistance in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saccà, F | 1 |
| Quarantelli, M | 1 |
| Rinaldi, C | 1 |
| Tucci, T | 1 |
| Piro, R | 1 |
| Perrotta, G | 1 |
| Carotenuto, B | 1 |
| Marsili, A | 1 |
| Palma, V | 1 |
| De Michele, G | 1 |
| Brunetti, A | 1 |
| Brescia Morra, V | 1 |
| Filla, A | 1 |
| Salvatore, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Patient Centric Motor Neuron Disease Activities of Daily Living Scale[NCT02852278] | 410 participants (Actual) | Observational | 2016-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for riluzole and Insulin Resistance
| Article | Year |
|---|---|
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Arginine; Choline; Creatine; Double-B | 2012 |